Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis and biological evaluation of coumarin-based N-hydroxycinnamamide derivatives as novel histone deacetylase inhibitors with anticancer activities
Jiaoli Ding, Jing Liu, Zhipeng Zhang, et al.
Bioorganic Chemistry (2020) Vol. 101, pp. 104023-104023
Closed Access | Times Cited: 21

Showing 21 citing articles:

Medicinal chemistry updates of novel HDACs inhibitors (2020 to present)
Xingrui He, Zi Hui, Li Xu, et al.
European Journal of Medicinal Chemistry (2021) Vol. 227, pp. 113946-113946
Closed Access | Times Cited: 55
Characterization of Histone Deacetylase Mechanisms in Cancer Development
Rihan Hai, Liuer He, Guang Shu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 46
Umbelliferone and Its Synthetic Derivatives as Suitable Molecules for the Development of Agents with Biological Activities: A Review of Their Pharmacological and Therapeutic Potential
Anita Kornicka, Łukasz Balewski, Monika Lahutta, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1732-1732
Open Access | Times Cited: 18
Design, synthesis, and herbicidal activity of novel phenoxypyridine derivatives containing natural product coumarin
Lixia Zhao, Zhixin Wang, Jian‐Feng Peng, et al.
Pest Management Science (2021) Vol. 77, Iss. 10, pp. 4785-4798
Closed Access | Times Cited: 22
Hydroxamic acid hybrids: Histone deacetylase inhibitors with anticancer therapeutic potency
Yuan Jiang Pan, Haodong Hou, Bo Zhou, et al.
European Journal of Medicinal Chemistry (2023) Vol. 262, pp. 115879-115879
Closed Access | Times Cited: 8
1,3,4-Thiadiazoline−coumarin hybrid compounds containing D-glucose/D-galactose moieties: Synthesis and evaluation of their antiproliferative activity
Vũ Ngọc Toán, Nguyễn Đình Thành, Tri Nguyen
Arabian Journal of Chemistry (2021) Vol. 14, Iss. 4, pp. 103053-103053
Open Access | Times Cited: 17
Novel thiazoline–coumarin hybrid compounds containing sugar moieties: synthesis, biological evaluation and molecular docking study as antiproliferative agents
Vũ Ngọc Toán, Nguyễn Đình Thành
New Journal of Chemistry (2021) Vol. 45, Iss. 24, pp. 10636-10653
Closed Access | Times Cited: 14
Recent Literature Review on Coumarin Hybrids as Potential Anticancer Agents
Naresh Kumar Katari, Muhammad D. Bala, Baji Baba Shaik, et al.
Anti-Cancer Agents in Medicinal Chemistry (2022) Vol. 23, Iss. 2, pp. 142-163
Closed Access | Times Cited: 10
Coumarin-derived Hydroxamic Acids as Histone Deacetylase Inhibitors: A Review of Anti-cancer Activities
Nguyen Quang Khai, Tran Khac Vu
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 24, Iss. 1, pp. 18-29
Closed Access | Times Cited: 5
Design of Fluorescent Coumarin-Hydroxamic Acid Derivatives as Inhibitors of HDACs: Synthesis, Anti-Proliferative Evaluation and Docking Studies
S. Maceda García, Itzel Mercado‐Sánchez, Luis Córdova-Bahena, et al.
Molecules (2020) Vol. 25, Iss. 21, pp. 5134-5134
Open Access | Times Cited: 14
Recent developments of hydroxamic acid hybrids as potential anti-breast cancer agents
Xinran Cao, Yufeng Gong
Future Medicinal Chemistry (2024) Vol. 16, Iss. 5, pp. 469-492
Open Access | Times Cited: 1
Anticancer effects of the HDAC inhibitor, 3β,6β‑dihydroxyurs‑12‑en‑27‑oic acid, in MCF‑7 breast cancer cells via the inhibition of Akt/mTOR pathways
Jong‐Seok Lim, So Young Kyung, Yukyoung Jeon, et al.
Oncology Reports (2023) Vol. 49, Iss. 2
Open Access | Times Cited: 4
Effect of pH on Fluorescence Spectra of Coumarin Derivatives
Zain ul Huda, Asim Mansha, Sadia Asim, et al.
Journal of Fluorescence (2021) Vol. 32, Iss. 1, pp. 57-66
Closed Access | Times Cited: 7
Design, synthesis and biological evaluation of Novel 6-azophenylcoumarin-3-formamido derivatives and a copper (II) complex
Jiongya Tang, Wen Lu, Jiayi Hu, et al.
Journal of Molecular Structure (2023) Vol. 1301, pp. 137448-137448
Closed Access | Times Cited: 2
A novel aggregation induced emission probe based on coumarin scaffold for imaging hypochlorite in cells and zebrafish
Xinrui Yang, Liying Jin, Yuheng Chen, et al.
Journal of Photochemistry and Photobiology A Chemistry (2021) Vol. 419, pp. 113464-113464
Closed Access | Times Cited: 6
Chromatographic descriptors in QSAR examination of the N, N -disubstituted chloroacetamides’ bioactivity
Suzana Apostolov, Aleksandra Bogdanović, Slobodan Petrović, et al.
Journal of Liquid Chromatography & Related Technologies (2024) Vol. 47, Iss. 11-15, pp. 262-274
Closed Access
Fragment‐type 4‐azolylcoumarin derivatives with anticancer properties
Milena Simić, Miloš Petković, Predrag Jovanović, et al.
Archiv der Pharmazie (2021) Vol. 354, Iss. 11
Closed Access | Times Cited: 4
Predicting Glioma Cell Differentiation-inducing Drugs Using a Drug Repositioning Strategy
Yan-Rong Ye, Zhao-Qi Tang
Combinatorial Chemistry & High Throughput Screening (2022) Vol. 26, Iss. 2, pp. 339-346
Closed Access | Times Cited: 2
Design, synthesis, and cytotoxicity evaluation of novel indole-acylhydrazone derivatives of 4-pyridinone as potential histone deacetylase-2 inhibitors
Niloofar Naghi-Ganji, Lotfollah Saghaei, Farial Tavakoli, et al.
Research in Pharmaceutical Sciences (2022) Vol. 17, Iss. 5, pp. 572-584
Open Access | Times Cited: 1
Synthesis of New Coumarin Scaffold Bearing 2-Iminochromene Moiety
Reem A. K. Al‐Harbi
Acta chimica slovenica (2023) Vol. 70, Iss. 3, pp. 380-384
Open Access
Recent review on selective histone deacetylase inhibitors in cancer therapy
Aya I. Abd El-hameed, Mamdouh F. A. Mohamed, Eman A. M. Beshr
Deleted Journal (2023)
Open Access
Page 1

Scroll to top